These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 7438480)

  • 21. [Long-term effects of a combination of 25-hydroxycholecalciferol and 1-alpha-hydroxycholecalciferol on osteodystrophy in chronic hemodialysis patients].
    Sebert JL; Marie A; Kuntz D; Marie P; Gueris J; Smadja A; Fournier A; Quichaud J
    Rev Rhum Mal Osteoartic; 1981; 48(7-9):535-41. PubMed ID: 7291931
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Renal osteodystrophy.
    Teitelbaum SL
    Hum Pathol; 1984 Apr; 15(4):306-23. PubMed ID: 6370824
    [No Abstract]   [Full Text] [Related]  

  • 23. 1,25-Dihydroxyvitamin D in biological fluids: a simplified and sensitive assay.
    Eisman JA; Hamstra AJ; Kream BE; DeLuca HF
    Science; 1976 Sep; 193(4257):1021-3. PubMed ID: 1085035
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum levels of vitamin D metabolites and bone remodelling in hyperthyroidism.
    Jastrup B; Mosekilde L; Melsen F; Lund B; Lund B; Sørensen OH
    Metabolism; 1982 Feb; 31(2):126-32. PubMed ID: 6978987
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Renal osteodystrophy: alpha-Heremans Schmid glycoprotein/fetuin-A, matrix GLA protein serum levels, and bone histomorphometry.
    Coen G; Ballanti P; Balducci A; Grandi F; Manni M; Mantella D; Pierantozzi A; Ruggeri M; Sardella D; Sorbo G; Bonucci E
    Am J Kidney Dis; 2006 Jul; 48(1):106-13. PubMed ID: 16797392
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Parathormone, calcitonin, 25-hydroxycalciferol and bone histology in patients with chronic renal insufficiency].
    Kokot F; Kuska J; Sledziński Z; Białas B; Luciak M
    Z Gesamte Inn Med; 1979 Nov; 34(22):665-70. PubMed ID: 549299
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 1,25-Dihydroxycholecalciferol in human serum and its relationship with other metabolites of vitamin D-3.
    Taylor CM; Hann J; St John J; Wallace JE; Mawer EB
    Clin Chim Acta; 1979 Aug; 96(1-2):1-8. PubMed ID: 225061
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vitamin D metabolism and osteomalacia in cystic fibrosis.
    Friedman HZ; Langman CB; Favus MJ
    Gastroenterology; 1985 Mar; 88(3):808-13. PubMed ID: 3871414
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum 1,25-dihydroxyvitamin D levels in normal children and in vitamin D disorders.
    Chesney RW; Rosen JF; Hamstra AJ; DeLuca HF
    Am J Dis Child; 1980 Feb; 134(2):135-9. PubMed ID: 7352436
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum concentrations of 24,25(OH)2D in uremic children: a reflection of renal function.
    Weisman Y; Lum GM; Reiter EO; Gilboa N; Knox GF; Root AW
    J Pediatr; 1979 Feb; 94(2):190-3. PubMed ID: 762605
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum 25-hydroxycholecalciferol in uremia.
    Offermann G; von Herrath D; Schaefer K
    Nephron; 1974; 13(4):269-77. PubMed ID: 4608520
    [No Abstract]   [Full Text] [Related]  

  • 32. Influence of the vitamin D-binding protein on the serum concentration of 1,25-dihydroxyvitamin D3. Significance of the free 1,25-dihydroxyvitamin D3 concentration.
    Bouillon R; Van Assche FA; Van Baelen H; Heyns W; De Moor P
    J Clin Invest; 1981 Mar; 67(3):589-96. PubMed ID: 6894152
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bone mineral loss, bone histomorphometry and vitamin D metabolism in patients with rheumatoid arthritis on long-term glucocorticoid treatment.
    Lund B; Storm TL; Lund B; Melsen F; Mosekilde L; Andersen RB; Egmose C; Sørensen OH
    Clin Rheumatol; 1985 Jun; 4(2):143-9. PubMed ID: 4006384
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pathogenesis of renal osteodystrophy: roles of phosphate and skeletal resistance to PTH.
    Ritz E; Malluche HH; Krempien B; Tschope W; Massry SG
    Adv Exp Med Biol; 1978; 103():423-36. PubMed ID: 362849
    [No Abstract]   [Full Text] [Related]  

  • 35. Demonstration of a lack of change in serum 1 alpha,25-dihydroxyvitamin D in response to parathyroid extract in pseudohypoparathyroidism.
    Lambert PW; Hollis BW; Bell NH; Epstein S
    J Clin Invest; 1980 Oct; 66(4):782-91. PubMed ID: 7419719
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of aluminum on normal and uremic rats: tissue distribution, vitamin D metabolites, and quantitative bone histology.
    Chan YL; Alfrey AC; Posen S; Lissner D; Hills E; Dunstan CR; Evans RA
    Calcif Tissue Int; 1983 May; 35(3):344-51. PubMed ID: 6871765
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum alkaline phosphatase in azotemic and hemodialysis osteodystrophy: a study of isoenzyme patterns, their correlation with bone histology, and their changes in response to treatment with 1alphaOHD3 and 1,25(OH)2D3.
    Pierides AM; Skillen AW; Ellis HA
    J Lab Clin Med; 1979 Jun; 93(6):899-909. PubMed ID: 438610
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence for extrarenal production of 1 alpha ,25-dihydroxyvitamin D in man.
    Lambert PW; Stern PH; Avioli RC; Brackett NC; Turner RT; Greene A; Fu IY; Bell NH
    J Clin Invest; 1982 Mar; 69(3):722-5. PubMed ID: 6895901
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Decreased serum 24,25-dihydroxy vitamin D concentrations in children receiving chronic anticonvulsant therapy.
    Weisman Y; Fattal A; Eisenberg Z; Harel S; Spirer Z; Harell A
    Br Med J; 1979 Sep; 2(6189):521-3. PubMed ID: 497670
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Concentrations of 24,25-dihydroxyvitamin D and 25-hydroxyvitamin D in paired maternal-cord sera.
    Weisman Y; Occhipinti M; Knox G; Reiter E; Root A
    Am J Obstet Gynecol; 1978 Mar; 130(6):704-7. PubMed ID: 637086
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.